首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1885905

血小板市場機會、成長促進因素、產業趨勢分析及預測（2025-2034年）

Blood Platelets Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

出版日期: 2025年11月25日 | 出版商:

Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024 年全球血小板市場價值為 59 億美元，預計到 2034 年將以 3.9% 的複合年成長率成長至 88 億美元。

市場擴張的促進因素包括輸血需求的成長、人們對捐血和血小板輸注意的提高，以及慢性病和血液疾病盛行率的上升。此外，外科手術和急診住院人數的增加也進一步刺激了需求。血小板處理和儲存技術的創新、人工血小板和冷凍乾燥血小板的研發，以及生技公司之間的策略合作，都是關鍵的成長因素。血小板在凝血和預防過度出血方面發揮著至關重要的作用，因此對於創傷護理、手術以及接受化療或其他強化治療的患者來說必不可少。各國政府、醫院網路和全球血液組織都在支持血小板輸注在全球的應用。

市場範圍
起始年份	2024
預測年份	2025-2034
起始值	59億美元
預測值	88億美元
複合年成長率	3.9%

2024年，單採血小板市佔率為53.1%。單採血小板直接從捐血者體內採集，採用自動化單採系統，在分離血小板的同時保留其他血液成分。這種方法每次捐血可獲得更高的血小板量，並最大限度地降低同種免疫和輸血相關感染的風險。單採血小板對於需要多次輸血的患者尤其重要，例如接受癌症治療或骨髓移植的患者。

2024年，血液腫瘤領域的市場估值為15億美元。此領域涵蓋血液癌症的治療，包括白血病、淋巴瘤和骨髓瘤，其中血小板輸注對於控制化療引起的血小板減少症至關重要。接受強化癌症治療的患者通常需要反覆輸注血小板以降低出血併發症的風險。

2024年，北美血小板市場佔據了26.8%的顯著佔有率。該地區先進的醫療基礎設施、民眾對捐血的廣泛認知以及癌症治療、創傷治療和複雜外科手術中對輸血的強勁需求，共同推動了市場的發展。自動化血小板分離系統和病原體去活化技術的應用，確保了安全性和營運效率。政府扶持的廣泛血小板捐贈網路，提高了血小板的供應量。

全球血小板市場的主要參與者包括美國血液中心、美國血庫協會 (AABB)、美國紅十字會、美國血液中心、巴西紅十字會、加拿大血液服務中心、法國紅十字會、德國紅十字會、印度紅十字會、義大利紅十字會、日本紅十字會、OneBlood、中國紅十字會、南非紅十字會、西班牙紅十字會、歐洲血液聯盟 (EBA) 和義大利國家血統中心。這些血小板企業正透過多種策略鞏固其市場地位。他們專注於技術創新，包括自動化血球分離系統和病原體去活化方法，以提高安全性、效率和產品品質。與醫院、醫療保健機構和當地捐血網路建立策略合作夥伴關係，可以擴大地域覆蓋範圍並提高捐血者的可及性。企業也投資研發人工血小板和冷凍乾燥血小板，以延長保存期限並減少對捐血者的依賴。

產業生態系分析
產業影響因素
- 成長促進因素
  - 慢性病和血液相關疾病的盛行率不斷上升
  - 輸血需求不斷成長
  - 提高大眾對捐血和血小板輸注的認知
  - 手術數量不斷增加
- 產業陷阱與挑戰
  - 感染傳播風險高
  - 治療費用高昂
- 機會
  - 血小板富集血漿（PRP）在再生醫學的應用拓展
  - 自動化血小板生產技術進步
成長潛力分析
監管環境
- 北美洲
- 歐洲
- 亞太地區
- 拉丁美洲
技術與創新格局
- 當前技術趨勢
- 新興技術
報銷方案
2021-2034年各地區價格分析
- 北美洲
  - 美國
  - 加拿大
- 歐洲
  - 德國
  - 英國
  - 法國
  - 西班牙
  - 義大利
- 亞太地區
  - 中國
  - 日本
  - 印度
  - 澳洲
  - 韓國
- 拉丁美洲
  - 巴西
  - 墨西哥
  - 阿根廷
- MEA
  - 南非
  - 沙烏地阿拉伯
  - 阿拉伯聯合大公國
供應鏈和物流面臨的挑戰
宣傳活動對捐款率的影響
未來市場趨勢
差距分析
波特的分析
PESTEL 分析

第4章：競爭格局

介紹
公司矩陣分析
公司市佔率分析
- 全球的
- 北美洲
- 歐洲
- 亞太地區
- 拉丁美洲
主要市場參與者的競爭分析
競爭定位矩陣
關鍵進展
- 併購
- 合作夥伴關係與合作
- 新產品發布
- 擴張計劃

第5章：市場估計與預測：依血小板類型分類，2021-2034年

主要趨勢
全血來源的血小板
血漿置換法所獲得的血小板

第6章：市場估算與預測：依應用領域分類，2021-2034年

主要趨勢
血友病
血小板減少症
圍手術期適應症
血小板功能障礙
血液腫瘤學
其他應用

第7章：市場估算與預測：依最終用途分類，2021-2034年

主要趨勢
醫院
門診手術中心
其他最終用途

第8章：市場估算與預測：依地區分類，2021-2034年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
MEA
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國

第9章：公司簡介

American Association of Blood Banks (AABB)
American National Red Cross
America's Blood Centers
Blood Centers of America
Brazilian Red Cross
Canada Blood Services
French Red Cross
German Red Cross
Indian Red Cross Society
Italian Red Cross
Japanese Red Cross Society
OneBlood
Red Cross Society of China
South African Red Cross
Spanish Red Cross
歐洲血液聯盟（EBA）
The Italian National Blood Centre

簡介目錄

Product Code: 2849

The Global Blood Platelets Market was valued at USD 5.9 billion in 2024 and is estimated to grow at a CAGR of 3.9% to reach USD 8.8 billion by 2034.

The expansion of the market is driven by the increasing demand for blood transfusions, rising awareness of blood donation and platelet transfusion, and the growing prevalence of chronic and hematological disorders. Additionally, the rising number of surgical procedures and emergency hospitalizations further fuels the demand. Innovations in platelet processing and storage, development of artificial and lyophilized platelets, and strategic collaborations between biotech companies are key growth factors. Platelets play a critical role in clotting and preventing excessive bleeding, making them essential for trauma care, surgery, and patients undergoing chemotherapy or other intensive treatments. Government initiatives, hospital networks, and global blood organizations are supporting the adoption of platelet transfusions worldwide.

Market Scope
Start Year	2024
Forecast Year	2025-2034
Start Value	$5.9 Billion
Forecast Value	$8.8 Billion
CAGR	3.9%

The apheresis-derived platelets segment held a 53.1% share in 2024. Platelets are collected directly from individual donors using automated apheresis systems that separate platelets while returning other blood components. This method produces higher platelet volumes per donation and minimizes risks associated with alloimmunization and transfusion-related infections. Apheresis platelets are especially critical for patients requiring multiple transfusions, such as those undergoing cancer therapy or bone marrow transplants.

The hemato-oncology segment was valued at USD 1.5 billion in 2024. This segment covers blood cancer treatments, including leukemia, lymphoma, and myeloma, where platelet transfusions are vital to manage chemotherapy-induced thrombocytopenia. Patients undergoing intensive cancer treatments frequently require repeated platelet transfusions to reduce the risk of bleeding complications.

North America Blood Platelets Market held a significant 26.8% share in 2024. The region's advanced healthcare infrastructure, robust awareness of blood donation, and strong demand for transfusions in cancer care, trauma treatment, and complex surgical procedures drive the market. Adoption of automated apheresis systems and pathogen reduction technologies ensures safety and operational efficiency. Extensive platelet donation networks supported by government initiatives enhance the availability of blood platelets.

Prominent companies operating in the Global Blood Platelets Market include America's Blood Centers, American Association of Blood Banks (AABB), American National Red Cross, Blood Centers of America, Brazilian Red Cross, Canada Blood Services, French Red Cross, German Red Cross, Indian Red Cross Society, Italian Red Cross, Japanese Red Cross Society, OneBlood, Red Cross Society of China, South African Red Cross, Spanish Red Cross, the European Blood Alliance (EBA), and the Italian National Blood Centre. Companies in the Blood Platelets Market are strengthening their position through multiple strategies. They focus on technological innovation, including automated apheresis systems and pathogen reduction methods, to improve safety, efficiency, and product quality. Strategic partnerships with hospitals, healthcare providers, and local blood donation networks expand geographic reach and improve donor accessibility. Firms invest in R&D to develop artificial and lyophilized platelets that enhance shelf life and reduce dependency on donors.

Chapter 1 Methodology and Scope

1.1 Market scope and definition
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Data mining sources
- 1.3.1 Global
- 1.3.2 Regional/Country
1.4 Base estimates and calculations
- 1.4.1 Base year calculation
- 1.4.2 Key trends for market estimation
1.5 Primary research and validation
- 1.5.1 Primary sources
1.6 Forecast model
1.7 Research assumptions and limitations

Chapter 2 Executive Summary

2.1 Industry 360° synopsis
2.2 Key market trends
- 2.2.1 Regional trends
- 2.2.2 Platelet type trends
- 2.2.3 Application trends
- 2.2.4 End Use trends
2.3 CXO perspectives: Strategic imperatives
- 2.3.1 Key decision points for industry executives
- 2.3.2 Critical success factors for market players
2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of chronic and blood-related disorders
  - 3.2.1.2 Growing demand for blood transfusions
  - 3.2.1.3 Rise in awareness regarding blood donations and platelets transfusions
  - 3.2.1.4 Rising number of surgical procedures
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High risk of transmissions of infections
  - 3.2.2.2 High cost of the treatment
- 3.2.3 Opportunities
  - 3.2.3.1 Expansion of platelet-rich plasma (PRP) applications in regenerative medicine
  - 3.2.3.2 Technological advancements in automated platelet production
3.3 Growth potential analysis
3.4 Regulatory landscape
- 3.4.1 North America
- 3.4.2 Europe
- 3.4.3 Asia Pacific
- 3.4.4 LAMEA
3.5 Technology and innovation landscape
- 3.5.1 Current technological trends
- 3.5.2 Emerging technologies
3.6 Reimbursement scenario
3.7 Pricing analysis, by region, 2021-2034
- 3.7.1 North America
  - 3.7.1.1 U.S.
  - 3.7.1.2 Canada
- 3.7.2 Europe
  - 3.7.2.1 Germany
  - 3.7.2.2 UK
  - 3.7.2.3 France
  - 3.7.2.4 Spain
  - 3.7.2.5 Italy
- 3.7.3 Asia Pacific
  - 3.7.3.1 China
  - 3.7.3.2 Japan
  - 3.7.3.3 India
  - 3.7.3.4 Australia
  - 3.7.3.5 South Korea
- 3.7.4 Latin America
  - 3.7.4.1 Brazil
  - 3.7.4.2 Mexico
  - 3.7.4.3 Argentina
- 3.7.5 MEA
  - 3.7.5.1 South Africa
  - 3.7.5.2 Saudi Arabia
  - 3.7.5.3 UAE
3.8 Challenges in supply chain and logistics
3.9 Impact of awareness campaigns on donation rates
3.10 Future market trends
3.11 Gap analysis
3.12 Porter's analysis
3.13 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
- 4.3.1 Global
- 4.3.2 North America
- 4.3.3 Europe
- 4.3.4 Asia Pacific
- 4.3.5 LAMEA
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Key developments
- 4.6.1 Mergers & acquisitions
- 4.6.2 Partnerships & collaborations
- 4.6.3 New product launches
- 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Platelet Type, 2021 - 2034 ($ Mn & Units)

5.1 Key trends
5.2 Whole-blood derived platelet
5.3 Apheresis derived platelets

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

6.1 Key trends
6.2 Hemophilia
6.3 Thrombocytopenia
6.4 Perioperative indications
6.5 Platelet function disorders
6.6 Hemato-oncology
6.7 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

7.1 Key trends
7.2 Hospitals
7.3 Ambulatory surgical centers
7.4 Other End Use

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn & Units)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
8.6 MEA
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE